have the opportunity to help us find a cure, to a permanent solution
for the complex problems of type 1 diabetes (T1D) and to a world that
shines ever more brightly for all those who now face the daily burden of
this disease. The Fund A Cure program is an example of how together we
can arm JDRF – the largest funder of T1D research in the world – with
the resources that nurture innovative ideas, prove their effectiveness
in the lab and ultimately reach our loved ones in the form of a cure for
T1D is an autoimmune disease striking 3 million children and adults in
the United States. Destroying the cells in the pancreas that produce
insulin, it causes lifelong dependence on injected insulin and carries
the constant threat of devastating, life-threatening, complications. It
requires intensive, never ending, 24/7 management. There are no days off
and there is no cure.
JDRF's cure-focused research identifies therapies to restore a person's
insulin producing capability and halt or reverse the body's misguided
attack on the pancreas. JDRF-funded research has rapidly advanced
results, for example:
As we work together to deliver a
cure, one face is inescapable: increased funding is essential.
Technology, clinical development and clinical trails are advancing fast
than ever before, and so are their costs. Please join us: give to Fund A
Cure this year!